Paper22249142
Host-tumor interactions in nasopharyngeal carcinomas.
Gourzones C and 2 others. Semin Cancer Biol, 2012. Cited by 91 papers, by iCite.
Cite this record
ConductScience Library. Host-tumor interactions in nasopharyngeal carcinomas. Papers, record 22249142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22249142
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytokines | Major topic |
| Nasopharyngeal Neoplasms | Major topic |
| T-Lymphocytes | Major topic |
| Tumor Microenvironment | Major topic |
| Carcinoma | |
| Chemokine CCL20 | |
| Epstein-Barr Virus Infections | |
| Exosomes | |
| Herpesvirus 4, Human | |
| Humans | |
| Models, Immunological | |
| Nasopharyngeal Carcinoma |
Source PubMed
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42587705 | Inflammatory-Hematological Profiles in Nasopharyngeal Carcinoma and Suspicious Adenoid Hypertrophy: An Exploratory Single-Center Study. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42587705 | PubMed |
| 41293174 | Reduced expression of UPF1 promotes tumor progression through stabilizing COX-2 mRNA in nasopharyngeal carcinoma. | Front Immunol | 2025 | https://conductscience.org/library/papers/41293174 | PubMed |
| 41073405 | Extracellular vesicles derived EBV tegument protein BRRF2 suppresses cGAS phase separation to promote anti-viral innate immune evasion. | Nat Commun | 2025 | https://conductscience.org/library/papers/41073405 | PubMed |
| 39891699 | KMO-driven metabolic reconfiguration and its impact on immune cell infiltration in nasopharyngeal carcinoma: a new avenue for immunotherapy. | Cancer Immunol Immunother | 2025 | https://conductscience.org/library/papers/39891699 | PubMed |
| 39822977 | Unveiling the complex double-edged sword role of exosomes in nasopharyngeal carcinoma. | PeerJ | 2025 | https://conductscience.org/library/papers/39822977 | PubMed |
| 39802901 | Fatty acid metabolism: A new target for nasopharyngeal carcinoma therapy. | Chin J Cancer Res | 2024 | https://conductscience.org/library/papers/39802901 | PubMed |
| 39789621 | Unveiling immune resistance mechanisms in nasopharyngeal carcinoma and emerging targets for antitumor immune response: tertiary lymphoid structures. | J Transl Med | 2025 | https://conductscience.org/library/papers/39789621 | PubMed |
| 39483474 | Nasopharyngeal carcinoma-associated inflammatory cytokines: ongoing biomarkers. | Front Immunol | 2024 | https://conductscience.org/library/papers/39483474 | PubMed |
| 38295746 | The role of tertiary lymphoid structure and B cells in nasopharyngeal carcinoma: Based on bioinformatics and experimental verification. | Transl Oncol | 2024 | https://conductscience.org/library/papers/38295746 | PubMed |
| 38206974 | EBV abortive lytic cycle promotes nasopharyngeal carcinoma progression through recruiting monocytes and regulating their directed differentiation. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/38206974 | PubMed |
| 38117000 | Extracellular vesicles derived from nasopharyngeal carcinoma induce the emergence of mature regulatory dendritic cells using a galectin-9 dependent mechanism. | J Extracell Vesicles | 2023 | https://conductscience.org/library/papers/38117000 | PubMed |
| 37932756 | Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect. | J Transl Med | 2023 | https://conductscience.org/library/papers/37932756 | PubMed |
| 37869238 | Update on Radiotherapy Changes of Nasopharyngeal Carcinoma Tumor Microenvironment. | World J Oncol | 2023 | https://conductscience.org/library/papers/37869238 | PubMed |
| 37417358 | Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review). | Int J Oncol | 2023 | https://conductscience.org/library/papers/37417358 | PubMed |
| 36726072 | Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer. | BMC Cancer | 2023 | https://conductscience.org/library/papers/36726072 | PubMed |
| 36618352 | Cuproptosis related genes associated with Jab1 shapes tumor microenvironment and pharmacological profile in nasopharyngeal carcinoma. | Front Immunol | 2022 | https://conductscience.org/library/papers/36618352 | PubMed |
| 36420735 | Latent membrane protein 1 and macrophage-derived TNFα synergistically activate and mobilize invadopodia to drive invasion of nasopharyngeal carcinoma. | J Pathol | 2023 | https://conductscience.org/library/papers/36420735 | PubMed |
| 35964134 | Revealing the crosstalk between nasopharyngeal carcinoma and immune cells in the tumor microenvironment. | J Exp Clin Cancer Res | 2022 | https://conductscience.org/library/papers/35964134 | PubMed |
| 35873027 | The emergence of tumor-infiltrating lymphocytes in nasopharyngeal carcinoma: Predictive value and immunotherapy implications. | Genes Dis | 2022 | https://conductscience.org/library/papers/35873027 | PubMed |
| 35527781 | Multilevel mechanism of immune checkpoint inhibitor action in solid tumors: History, present issues and future development. | Oncol Lett | 2022 | https://conductscience.org/library/papers/35527781 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCL20 | 6364 | PubTator's text mining | https://conductscience.org/library/genes/6364 | NCBI Gene |
| LGALS9 | 3965 | PubTator's text mining | https://conductscience.org/library/genes/3965 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22249142
GET https://conductscience.org/api/papers/v1/22249142/cited_by?page=2